Hospira Boulder, Inc.

Form 483 issued May 27, 2015 · Lake Forest, Illinois

Inspection
Apr 20 – May 27, 2015
Observations
4
Pages
6
FEI number
3005579246

In short: On May 27, 2015, FDA issued a Form 483 with 4 observations to Hospira Boulder, Inc. in Lake Forest, Illinois (FEI 3005579246) after an inspection that ran Apr 20 – May 27, 2015. The investigators were Phillip M. Pontikos and Rafael Padilla. Most observations concern design controls and cAPA; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

3 of 4 observations on this 483 concern design controls.

Design controls3
CAPA1

Most cited: 21 CFR 820.30 (3×) · 820.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures for design validation have…

  2. 02

    The device design was not correctly…

  3. 03

    Procedures for design change have…

  4. 04

    Procedures for corrective and preventive action have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Hospira Boulder, Inc.?

FDA listed 4 observations on this Form 483, mostly about design controls and cAPA. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Hospira Boulder, Inc.?

Phillip M. Pontikos and Rafael Padilla are named on this Form 483, for the inspection of Apr 20 – May 27, 2015. Each investigator has a profile showing what they cite most.

When was Hospira Boulder, Inc. inspected by FDA?

The inspection ran Apr 20 – May 27, 2015, and the Form 483 is dated May 27, 2015.

How do I get the full Form 483 for Hospira Boulder, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free